2013-2028 Report on Global Anti-Obesity Prescription Drugs Market by Player, Region, Type, Application and Sales Channel

Published: Dec, 2018 | Pages: 115 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Global anti-obesity prescription drugs market is forecasted to grow at an exponential CAGR by the year 2028. Anti-obesity prescription drugs are the medicines approved for the treatment of reducing excess weight.

“Obesity can be accredited as an incurable chronic disease that intensifies the risk of cardiovascular diseases like hypertension, diabetes, and strokes. In severe conditions, lifestyle intervention fails to impart potential results and a large proportion of patients obvert their customary standards to optimize positive clinical outcome with the consumption of prescribed weight loss drugs.”

Rising awareness among the general population regarding the side-effects of obesity is set to drive market growth. Also, growing disposable income has surged healthcare expenditure and the presence of suitable reimbursement policies have further propelled the development of anti-obesity prescription drugs market. However, some of these drugs have registered potential adverse health impact and is hampering the market progression. 

Few of these such as Rrimonabant, Amphetamine, and Sibutramine licenses have been withdrawn by the FDA due to the growing risk of psychiatric disorders and non-fatal myocardial infarction associated with its consumption. Furthermore, an inclination towards incorporating yoga and functional training into their lifestyle is creating a hindrance for drug administration.

By drug class, the anti-obesity prescription drugs market has been segmented into Bupropion and Naltrexone, Lorcaserin, Phentermine and Topiramate, Orlistat, and Liraglutide. Based on age-group, the market has been categorized into adult and pediatric. The key players have identified distribution channels to classify the market into Hospital Pharmacies, E-Commerce, and Retail Pharmacies among others. 

The competitive landscape of the global anti-obesity prescription drugs market has identified the presence of major players dominating this industry. This includes GlaxoSmithKline, Arena Pharmaceuticals, Orexigen Therapeutics, Vivus, F Hoffmann La-Roche, Boehringer Ingelheim, Alizyme, Eisai, Novo Nordisk, and Takeda Pharmaceuticals among others. 

The European Medicines Agency (EMA) in the year 2000 retreated the utilization of a series of anti-obesity drugs attributed to an inadmissible proportion of risk to benefit ratio. Rimonabant, one such anti-obesity prescriptive drug was accessible in more than 55 countries but was later discovered to be retailed without being approved by the U.S. Food and Drug Administration (FDA). Its use logged on to an enlarging occurrence of adverse psychiatric events, including suicidal ideation, depression, and anxiety. 

Subsequently, in the year 2009, Rimonabant was withdrawn from the European anti-obesity prescription drugs market. Recently, numerous innovative agents have been tested and examined, but only sibutramine and orlistat have been approved for long-term use. 

The global Anti-Obesity Prescription Drugs market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028.

This report provides detailed historical analysis of global market for Anti-Obesity Prescription Drugs from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Anti-Obesity Prescription Drugs market.

Leading players of Anti-Obesity Prescription Drugs including:

•	F Hoffmann La Roche
•	Arena Pharmaceuticals
•	Orexigen Therapeutics
•	Phentermine and Topiramate
•	VIVUS, Inc
•	Liraglutide
•	Bupropion and Naltrexone
•	Orlistat
•	Bupropion and Naltrexone
•	Novo Nordisk
•	Lorcaserin

Market split by Type, can be divided into:

•	Oral Medicine
•	Diet Patch
•	Other

Market split by Application, can be divided into:

•	Hospitals Pharmacies
•	Retail Pharmacies
•	E-commerce

Market split by Sales Channel, can be divided into:

•	Direct Channel
•	Distribution Channel

Market segment by Region/Country including:

•	North America (United States, Canada and Mexico)
•	Europe (Germany, UK, France, Italy, Russia and Spain etc.)
•	Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
•	South America Brazil, Argentina, Colombia and Chile etc.)
•	Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 Anti-Obesity Prescription Drugs Market Overview
    1.1 Anti-Obesity Prescription Drugs Definition
    1.2 Global Anti-Obesity Prescription Drugs Market Size Status and Outlook (2013-2028)
    1.3 Global Anti-Obesity Prescription Drugs Market Size Comparison by Region (2013-2028)
    1.4 Global Anti-Obesity Prescription Drugs Market Size Comparison by Type (2013-2028)
    1.5 Global Anti-Obesity Prescription Drugs Market Size Comparison by Application (2013-2028)
    1.6 Global Anti-Obesity Prescription Drugs Market Size Comparison by Sales Channel (2013-2028)
    1.7 Anti-Obesity Prescription Drugs Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)

Chapter 2 Anti-Obesity Prescription Drugs Market Segment Analysis by Player
    2.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Player (2016-2018)
    2.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Player (2016-2018)
    2.3 Global Anti-Obesity Prescription Drugs Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player

Chapter 3 Anti-Obesity Prescription Drugs Market Segment Analysis by Type
    3.1 Global Anti-Obesity Prescription Drugs Market by Type
        3.1.1 Oral Medicine
        3.1.2 Diet Patch
        3.1.3 Other
    3.2 Global Anti-Obesity Prescription Drugs Sales and Market Share by Type (2013-2018)
    3.3 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Type (2013-2018)
    3.4 Global Anti-Obesity Prescription Drugs Average Price by Type (2013-2018)
    3.5 Leading Players of Anti-Obesity Prescription Drugs by Type in 2017
    3.6 Conclusion of Segment by Type

Chapter 4 Anti-Obesity Prescription Drugs Market Segment Analysis by Application
    4.1 Global Anti-Obesity Prescription Drugs Market by Application
        4.1.1 Hospitals Pharmacies
        4.1.2 Retail Pharmacies
        4.1.3 E-commerce
    4.2 Global Anti-Obesity Prescription Drugs Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Anti-Obesity Prescription Drugs by Application in 2017
    4.4 Conclusion of Segment by Application

Chapter 5 Anti-Obesity Prescription Drugs Market Segment Analysis by Sales Channel
    5.1 Global Anti-Obesity Prescription Drugs Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Anti-Obesity Prescription Drugs Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Anti-Obesity Prescription Drugs by Sales Channel in 2017
    5.4 Conclusion of Segment by Sales Channel

Chapter 6 Anti-Obesity Prescription Drugs Market Segment Analysis by Region
    6.1 Global Anti-Obesity Prescription Drugs Market Size and CAGR by Region (2013-2028)
    6.2 Global Anti-Obesity Prescription Drugs Sales and Market Share by Region (2013-2018)
    6.3 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Anti-Obesity Prescription Drugs Market Share by Type
        6.4.3 North America Anti-Obesity Prescription Drugs Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Anti-Obesity Prescription Drugs Market Share by Type
        6.5.3 Europe Anti-Obesity Prescription Drugs Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Anti-Obesity Prescription Drugs Market Share by Type
        6.6.3 Asia-Pacific Anti-Obesity Prescription Drugs Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Anti-Obesity Prescription Drugs Market Share by Type in 2017
        6.7.3 South America Anti-Obesity Prescription Drugs Market Share by Application in 2017
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Anti-Obesity Prescription Drugs Market Share by Type
        6.8.3 Middle East & Africa Anti-Obesity Prescription Drugs Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Anti-Obesity Prescription Drugs Players
    7.1 F Hoffmann La Roche
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Arena Pharmaceuticals
    7.3 Orexigen Therapeutics
    7.4 Phentermine and Topiramate
    7.5 VIVUS, Inc
    7.6 Liraglutide
    7.7 Bupropion and Naltrexone
    7.8 Orlistat
    7.9 Bupropion and Naltrexone
    7.10 Novo Nordisk
    7.11 Lorcaserin

Chapter 8 Upstream and Downstream Analysis of Anti-Obesity Prescription Drugs
    8.1 Industrial Chain of Anti-Obesity Prescription Drugs
    8.2 Upstream of Anti-Obesity Prescription Drugs
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Anti-Obesity Prescription Drugs
        8.3.1 Leading Distributors/Dealers of Anti-Obesity Prescription Drugs
        8.3.2 Leading Consumers of Anti-Obesity Prescription Drugs

Chapter 9 Development Trend of Anti-Obesity Prescription Drugs (2018-2028)
    9.1 Global Anti-Obesity Prescription Drugs Market Size (Sales and Revenue) Forecast (2018-2028)
    9.2 Global Anti-Obesity Prescription Drugs Market Size and CAGR Forecast by Region (2018-2028)
    9.3 Global Anti-Obesity Prescription Drugs Market Size and CAGR Forecast by Type (2018-2028)
    9.4 Global Anti-Obesity Prescription Drugs Market Size and CAGR Forecast by Application (2018-2028)
    9.5 Global Anti-Obesity Prescription Drugs Market Size Forecast by Sales Channel (2018-2028)

Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure Anti-Obesity Prescription Drugs Example
    Figure Global Anti-Obesity Prescription Drugs Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Anti-Obesity Prescription Drugs Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Anti-Obesity Prescription Drugs Sales Comparison by Type (2013-2028)
    Figure Global Anti-Obesity Prescription Drugs Sales Comparison by Application (2013-2028)
    Figure Global Anti-Obesity Prescription Drugs Sales Comparison by Sales Channel (2013-2028)
    Table Global Anti-Obesity Prescription Drugs Sales by Player (2016-2018)
    Table Global Anti-Obesity Prescription Drugs Sales Market Share by Player (2016-2018)
    Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Player in 2017
    Table Global Anti-Obesity Prescription Drugs Revenue (Million $) by Player (2016-2018)
    Table Global Anti-Obesity Prescription Drugs Revenue Market Share by Player (2016-2018)
    Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Player in 2017
    Table Global Anti-Obesity Prescription Drugs Average Price by Player (2016-2018)
    Figure Global Anti-Obesity Prescription Drugs Average Price by Player in 2017
    Figure Global Anti-Obesity Prescription Drugs Players Competition Situation - Top 5 Players' Revenue Market Share in 2017
    Figure Global Anti-Obesity Prescription Drugs Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Oral Medicine
    Figure Global Oral Medicine Sales and Growth Rate (2013-2018)
    Figure Example of Diet Patch
    Figure Global Diet Patch Sales and Growth Rate (2013-2018)
    Figure Example of Other
    Figure Global Other Sales and Growth Rate (2013-2018)
    Table Global Anti-Obesity Prescription Drugs Sales by Type (2013-2018)
    Table Global Anti-Obesity Prescription Drugs Sales Market Share by Type (2013-2018)
    Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Type in 2017
    Table Global Anti-Obesity Prescription Drugs Revenue (Million $) by Type (2013-2018)
    Table Global Anti-Obesity Prescription Drugs Revenue Market Share by Type (2013-2018)
    Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Type in 2017
    Table Global Anti-Obesity Prescription Drugs Average Price by Type (2013-2018)
    Figure Global Anti-Obesity Prescription Drugs Average Price by Type in 2017
    Table Leading Players of Anti-Obesity Prescription Drugs by Type in 2017
    Figure Example of Hospitals Pharmacies
    Figure Global Anti-Obesity Prescription Drugs for Hospitals Pharmacies Sales and Growth Rate (2013-2018)
    Figure Example of Retail Pharmacies
    Figure Global Anti-Obesity Prescription Drugs for Retail Pharmacies Sales and Growth Rate (2013-2018)
    Figure Example of E-commerce
    Figure Global Anti-Obesity Prescription Drugs for E-commerce Sales and Growth Rate (2013-2018)
    Table Global Anti-Obesity Prescription Drugs Sales by Application (2013-2018)
    Table Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2013-2018)
    Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Application in 2017
    Table Leading Consumers of Anti-Obesity Prescription Drugs by Application in 2017
    Figure Example of Direct Channel
    Figure Global Anti-Obesity Prescription Drugs for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Anti-Obesity Prescription Drugs for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Anti-Obesity Prescription Drugs Sales by Sales Channel (2013-2018)
    Table Global Anti-Obesity Prescription Drugs Sales Market Share by Sales Channel (2013-2018)
    Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Sales Channel in 2017
    Table Leading Distributors/Dealers of Anti-Obesity Prescription Drugs by Sales Channel in 2017
    Table Global Anti-Obesity Prescription Drugs Market Size and CAGR by Region (2013-2028)
    Table Global Anti-Obesity Prescription Drugs Sales by Region (2013-2018)
    Table Global Anti-Obesity Prescription Drugs Sales Market Share by Region (2013-2018)
    Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Region in 2017
    Table Global Anti-Obesity Prescription Drugs Revenue (Million $) by Region (2013-2018)
    Table Global Anti-Obesity Prescription Drugs Revenue Market Share by Region (2013-2018)
    Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Region in 2017
    Table North America Anti-Obesity Prescription Drugs Sales by Country (2013-2018)
    Figure North America Anti-Obesity Prescription Drugs Sales Market Share by Country (2013-2018)
    Table North America Anti-Obesity Prescription Drugs Revenue by Country (2013-2018)
    Figure North America Anti-Obesity Prescription Drugs Revenue Market Share by Country (2013-2018)
    Figure North America Anti-Obesity Prescription Drugs Sales Market Share by Type in 2017
    Figure North America Anti-Obesity Prescription Drugs Sales Market Share by Application in 2017
    Figure United States Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure United States Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Canada Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Mexico Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Anti-Obesity Prescription Drugs Sales by Country (2013-2018)
    Figure Europe Anti-Obesity Prescription Drugs Sales Market Share by Country (2013-2018)
    Table Europe Anti-Obesity Prescription Drugs Revenue by Country (2013-2018)
    Figure Europe Anti-Obesity Prescription Drugs Revenue Market Share by Country (2013-2018)
    Figure Europe Anti-Obesity Prescription Drugs Sales Market Share by Type in 2017
    Figure Europe Anti-Obesity Prescription Drugs Sales Market Share by Application in 2017
    Figure Germany Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Germany Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure UK Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure France Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Italy Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Russia Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Spain Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Anti-Obesity Prescription Drugs Sales by Country (2013-2018)
    Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Anti-Obesity Prescription Drugs Revenue by Country (2013-2018)
    Figure Asia-Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Type in 2017
    Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Application in 2017
    Figure China Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure China Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Japan Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Korea Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure India Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Australia Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Anti-Obesity Prescription Drugs Sales by Country (2013-2018)
    Figure South America Anti-Obesity Prescription Drugs Sales Market Share by Country (2013-2018)
    Table South America Anti-Obesity Prescription Drugs Revenue by Country (2013-2018)
    Figure South America Anti-Obesity Prescription Drugs Revenue Market Share by Country (2013-2018)
    Figure South America Anti-Obesity Prescription Drugs Sales Market Share by Type in 2017
    Figure South America Anti-Obesity Prescription Drugs Sales Market Share by Application in 2017
    Figure Brazil Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Brazil Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Argentina Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Colombia Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Chile Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Anti-Obesity Prescription Drugs Sales by Country (2013-2018)
    Figure Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Anti-Obesity Prescription Drugs Revenue by Country (2013-2018)
    Figure Middle East & Africa Anti-Obesity Prescription Drugs Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Type in 2017
    Figure Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Application in 2017
    Figure Egypt Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Egypt Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure South Africa Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Anti-Obesity Prescription Drugs Sales and Growth Rate (2013-2018)
    Figure Nigeria Anti-Obesity Prescription Drugs Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of F Hoffmann La Roche
    Table Anti-Obesity Prescription Drugs Introduction of F Hoffmann La Roche
    Table Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share of F Hoffmann La Roche (2016-2018)
    Table Industrial Chain of Anti-Obesity Prescription Drugs
    Table Manufacturing Cost Structure of Anti-Obesity Prescription Drugs
    Table General Manufacturing Process of Anti-Obesity Prescription Drugs
    Table Leading Distributors/Dealers of Anti-Obesity Prescription Drugs
    Table Leading Consumers of Anti-Obesity Prescription Drugs
    Figure Global Anti-Obesity Prescription Drugs Sales and Growth Rate Forecast (2018-2028)
    Figure Global Anti-Obesity Prescription Drugs Revenue and Growth Rate Forecast (2018-2028)
    Table Global Anti-Obesity Prescription Drugs Market Size and CAGR Forecast by Region (2018-2028)
    Table Global Anti-Obesity Prescription Drugs Market Size and CAGR Forecast by Type (2018-2028)
    Table Global Anti-Obesity Prescription Drugs Market Size and CAGR Forecast by Application (2018-2028)
    Table Global Anti-Obesity Prescription Drugs Market Size and CAGR Forecast by Sales Channel (2018-2028)